BIOSECURE and Beyond: What it Really Means for Pharma Supply Chains

The US pharmaceutical industry is entering a new phase of supply chain transformation. Regulatory pressure, geopolitical uncertainty, new patient populations, and innovative modalities are forcing companies to rethink not only where medicines are produced, but how they move across an increasingly complex global landscape.